Related Experiment Video

Updated: Feb 15, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.7K

PARP1-siRNA suppresses human prostate cancer cell growth and progression

Yongchang Lai1, Zhenzhen Kong1, Tao Zeng1

  • 1Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Urology Research Institute, Guangdong Key Laboratory of Urology, Guangzhou 510230, P.R. China.

Oncology Reports
|February 3, 2018
PubMed

Insights

Small interfering RNA targeting Poly (ADP-ribose) polymerase 1 (PARP1-siRNA) effectively reduces prostate cancer progression and invasion. This novel approach, distinct from PARP inhibitors, shows therapeutic potential for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Poly (ADP-ribose) polymerase (PARP) inhibitors demonstrate efficacy in BRCA1/2-deficient tumors.
  • The distinct mechanism of PARP inhibitors (PARPi) modulating PARP activation, not expression, necessitates investigation into PARP1-specific small interfering RNA (siRNA).

Purpose of the Study:

  • To evaluate the functional efficacy of PARP1-siRNA in prostate cancer (PCa) progression, independent of BRCA1/2 mutation status.
  • To compare the effects of PARP1-siRNA with conventional PARPi on PCa cell behavior and molecular markers.

Main Methods:

  • Utilized PARP1-siRNA in PCa cell lines (PC3, Du145, C4-2) to assess proliferation, migration, invasion, and apoptosis.
  • Administered PARP1-siRNA in a xenograft nude mouse model to evaluate tumor growth suppression.
  • Analyzed epithelial-mesenchymal transition (EMT) markers (vimentin, E-cadherin) and specific signaling pathways (EGFR, p-GSK3β).

Main Results:

  • PARP1-siRNA significantly inhibited PCa cell migration, invasion, and proliferation across different cell lines.
  • PARP1-siRNA treatment increased cleaved-caspase3 levels, indicating enhanced apoptosis, and suppressed tumor growth in vivo.
  • PARP1-siRNA downregulated vimentin and upregulated E-cadherin, reversing EMT, and notably suppressed EGFR and p-GSK3β expression, differentiating it from PARPi effects.

Conclusions:

  • PARP1-siRNA effectively suppresses prostate cancer growth, invasion, and EMT.
  • PARP1-siRNA exhibits distinct molecular effects compared to PARPi, offering a potential novel therapeutic strategy for prostate cancer.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.9K
Pre-clinical Orthotopic Murine Model of Human Prostate Cancer07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

15.1K

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Cells Coordinate Growth and Proliferation02:36

Cells Coordinate Growth and Proliferation

Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
5.2K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.8K